Allergy Therapeutics plc has disclosed a Form 8.5 (EPT/RI) from Panmure Gordon (UK) Limited, an exempt principal trader with recognized intermediary status. The form provides key information regarding dealings in Allergy Therapeutics' securities. The date of dealing was October 4, 2023. The form includes details of purchases and sales of the company's 0.1p ordinary shares, with 239,704 shares purchased at a highest price per unit of 0.01426 and a lowest price per unit of 0.01426. There were no sales of the 0.1p ordinary shares. The form does not disclose any cash-settled derivative transactions or stock-settled derivative transactions. It also states that there are no indemnity or option arrangements, agreements, or understandings relating to relevant securities. The contact name provided is Freddie Wooding, with a telephone number of +44 (0)20 7886 2969.